GRAYBUG VISION Logo

Regeneron

New Treatment for Diabetic Macular Edema

Enrollment is Closed

About this Study

A randomized, double-masked, active-controlled phase 2/3 study of the efficacy and safety of high-dose aflibercept in patients with diabetic macular edema.

This study is using a higher concentration of Eylea with the hope that patients will need injections much less frequently, hopefully, every 3-4 months and still maintain visual improvements.

Aerpio Logo

Genentech Lucerne Study

Enrollment is Closed

This is a new drug called faricimab that may allow us to dose less frequently for wet AMD

Alcon Logo

Opthea

New Treatment for Neovascular Age-Related Macular Degeneration

Enrollment is Open

About this Study

This is a phase 3 study looking at adding a new molecule in addition to Lucentis or Eylea. It is hoped that patients will have better results and less frequent treatment.

Ocuphire New Treatment for Diabetic Eye Disease Study

New Treatment for Diabetic Eye Disease

Enrollment is Open

About this Study

This is a phase 2 study looking at an oral treatment (pill) to treat moderately severe to severe nonproliferative diabetes retinopathy and mild proliferation diabetic retinopathy.

Genentech Logo

Genentech Yosemite Study

New Treatment for Diabetic Macular Edema

Study is now closed

About this Study

This is a phase 3 study looking at a new drug RO6867461. It has the potential to improve vision with fewer eye injections.

Genentech Logo

GlaxoSmithKline Study

New treatment for diabetic macular edema

Enrollment is open

About this Study

Phase 1 study looking at an oral medication (pill) to treat diabetic macular edema.

For more detailed information about how Island Retina can help you see a brighter future, call us at one of our 2 convenient locations: Commack, NY 631-486-6672 or Shirley, NY 631-924-4300. You can also reach us by email through our website’s secure contact page.

Contact Us